Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 67

Sort by

Sort Order Select

Journal Articles

Mir-29 Maintains the Acute Myeloid Leukemia Epigenome By Regulating CBX2

Caryn J. Ha, BA, Wenhuo Hu, PhD, Harold K. Elias, MD, Sohini Chakraborty, PhD, Christopher Y. Park, MD PhD

Blood (2019) 134 (Supplement_1): 1236.

https://doi.org/10.1182/blood-2019-131518

Published: 2019

Journal Articles

Mutant TET2 Allele Dosage Affects Response to 5-Azacitidine in Acute Myeloid Leukemia

Blood (2019) 134 (Supplement_1): 113.

https://doi.org/10.1182/blood-2019-123047

Published: 2019

Journal Articles

Downregulation of MDM2 Leads to Anti-Proliferative Effects through Activation of p53-Associated Pathway Mediated By Both Dual Inhibitor MX69 and Mir-548c-3p in Multiple Myeloma

Faruq Faruq, PhD, Davidson Zhao, Jian Wu, MD, Jonahunnatha Nesson George William, PhD, Min Zhang, MD, Hong Chang, MD

Blood (2019) 134 (Supplement_1): 4419.

https://doi.org/10.1182/blood-2019-129430

Published: 2019

Journal Articles

Both Arid1b and Arid2 Are Tumor Suppressors in MLL-AF9 Leukemogenesis

Theresa Bluemn, Jesse Schmitz, Yongwei Zheng, PhD, Nan Zhu, PhD

Blood (2019) 134 (Supplement_1): 1248.

https://doi.org/10.1182/blood-2019-127123

Published: 2019

Journal Articles

An Alternative Pathway Specific Flow Cytometric Assay to Detect Complement Activation in Atypical Hemolytic Uremic Syndrome (aHUS)

Jia Yu, Xuan Yuan, MD MSc, Kang Zhou, Daniel White, Samuel A. Merrill, MD PhD, Robert A. Brodsky, MD

Blood (2018) 132 (Supplement 1): 3748.

https://doi.org/10.1182/blood-2018-99-119445

Published: 2018

Journal Articles

Integrin Activity Reduces Immunogenic Cell Death By Inhibiting Cell Surface Presentation of ERp57 and Calreticulin

Chi-Chao Liu, Pascal Leclair, Foujan Pedari, Monajemi Mahdis, Laura Sly, Gregor S. D. Reid, PhD, Chinten James Lim, PhD

Blood (2018) 132 (Supplement 1): 3927.

https://doi.org/10.1182/blood-2018-99-119550

Published: 2018

Journal Articles

The Histone Methyltransferase Setd8 Alters the Chromatin Landscape and Regulates the Expression of Key Transcription Factors during Erythroid Differentiation

Jacquelyn Lillis, Jeffrey Malik, PhD, Tyler A Couch, BS, Michael Getman, Laurie A. Steiner, MD

Blood (2018) 132 (Supplement 1): 2568.

https://doi.org/10.1182/blood-2018-99-110999

Published: 2018

Journal Articles

Epigenetic Regulation and Therapeutic Targeting in Myeloma

Jonathan D. Licht, MD

Blood (2018) 132 (Supplement 1): SCI-37.

https://doi.org/10.1182/blood-2018-99-109522

Published: 2018

Journal Articles

Temporal and Spatially Regulated Oncogenic KIT Expression and Loss of Dnmt3a Cooperate to Drive MPN Development: Role of PI3Kinase in Dnmt3a Loss Induced Hyperproliferation in Myeloid Cells

Lakshmi Reddy Palam, PhD, Baskar Ramdas, PhD, Sridhar reddy Srivatsan, MS, Sarath Chandra Janga, PhD, Axel Roers, PhD, Alexander Gerbaulet, Reuben Kapur, PhD

Blood (2018) 132 (Supplement 1): 3055.

https://doi.org/10.1182/blood-2018-99-118721

Published: 2018

Journal Articles

FANCN Hypomorphic Mutation Retains BRCA1 Binding Domain

Elizabeth Thompson, MS, Jakub Tolar, MD PhD, Eric A. Hendrickson, PhD

Blood (2016) 128 (22): 2676.

https://doi.org/10.1182/blood.V128.22.2676.2676

Published: 2016

Journal Articles

The Novel Thiosemicarbazone Derivative Coti-2 Induces Mitochondrial Apoptosis in Acute Myeloid Leukemia Cells Via a p53-Independent Mechanism

Dhruv Chachad, Jo Ishizawa, MD PhD, Wayne R Danter, MD, Gordon Mills, MD PhD, Michael Andreeff, MD PhD, Kensuke Kojima, MD, PhD

Blood (2016) 128 (22): 2757.

https://doi.org/10.1182/blood.V128.22.2757.2757

Published: 2016

Journal Articles

Integrative Analysis of the Mutational Landscape of Mouse and Human AML Identifies Functionally Relevant Leukemia Disease Alleles

Megan A. Hatlen, PhD, Kanika Arora, MS, Vladimir Vacic, PhD, Ewa A. Grabowska, BS, Willey Liao, BS, Bridget Riley-Gillis, PhD, Dayna M. Oschwald, BS, Lan Wang, PhD, Jacob E. Joergens, Alan H. Shih, MD PhD, Franck Rapaport, PhD, Shengqing Gu, PhD, Francesca Voza, BS, Takashi Asai, MD PhD, Benjamin Neel, MD PhD, Michael G. Kharas, PhD, Mithat Gonen, PhD, Ross L. Levine, MD, Stephen D. Nimer, MD

Blood (2015) 126 (23): 1247.

https://doi.org/10.1182/blood.V126.23.1247.1247

Published: 2015

Journal Articles

GABP Transcription Factor Is Required for B Lymphocyte Maturation and Plasma Cell Development

Zhongfa Yang, PhD, Yu Zhu, MD PhD, Rachel Gerstein, PhD, Alan G. Rosmarin, MD

Blood (2015) 126 (23): 1179.

https://doi.org/10.1182/blood.V126.23.1179.1179

Published: 2015

Journal Articles

Desuppressed Expressionsof MiR-29 targetsdisturb the Leukemeugenesis of MLL-AF9

Wenhuo Hu, PhD, Christopher Y. Park, MD, PhD

Blood (2015) 126 (23): 1228.

https://doi.org/10.1182/blood.V126.23.1228.1228

Published: 2015

Journal Articles

Megatal, Crispr/Cas9, and Talen T-Cell Receptor Gene Editing

Mark J. Osborn, PhD, Beau R Webber, PhD, Friederike Knipping, Cara-lin Lonetree, Anthony DeFeo, Amber McElroy, Colby Starker, PhD, Richard Gabriel, Sarah Merkel, Keli L. Hippen, PhD, Daniel Voytas, PhD, Christof von Kalle, MD, Manfred Schmidt, PhD, Jeffrey S. Miller, MD, Jordan Jarjour, PhD, Alexander Astrakhan, PhD, Andrew M Scharenberg, MD, Jakub Tolar, MD, PhD, Bruce R. Blazar, MD

Blood (2015) 126 (23): 2045.

https://doi.org/10.1182/blood.V126.23.2045.2045

Published: 2015

Journal Articles

MiR-29a is Essential in Leukemic Transformation and Maintaining Hematopoietic Stem Cell Self-Renewal

Wenhuo Hu, PhD, James Dooley, PhD, Luisa Cimmino, PhD, Adrian Liston, PhD, Christopher Y. Park, MD PhD

Blood (2014) 124 (21): 4792.

https://doi.org/10.1182/blood.V124.21.4792.4792

Published: 2014

Journal Articles

PRL2 Phosphatase Regulate Early Stage T-Cell Development through Fine-Tuning SCF/Kit Signaling

Kobayashi Michihiro, MD PhD, Yunpeng Bai, PhD, Momoko Yoshimoto, MD PhD, Rui Gao, PhD, Chen Sisi, Yuanshu Dong, PhD, Zhon-Yin Zhang, PhD, Yan Liu, PhD

Blood (2014) 124 (21): 1569.

https://doi.org/10.1182/blood.V124.21.1569.1569

Published: 2014

Journal Articles

Heightened DNA Damage Response and p53 Activation In MiR-155 Null Cells Are Context Specific and Aid Dependent

Hakim Bouamar, PhD, Long Wang, MD, Manoela Ortega, PhD, An-Ping Lin, MD, Daifeng Jiang, PhD, Ricardo Aguiar, MD, PhD

Blood (2013) 122 (21): 2279.

https://doi.org/10.1182/blood.V122.21.2279.2279

Published: 2013

Journal Articles

No Evidence For Routine CSF Cytology In Detecting Asymptomatic CNS Relapse In Children With Acute Lymphoblastic Leukaemia: 20 Years Experience Of a UK Primary Treatment Centre

Sue Manley, MB ChB, Russell Keenan, MB ChB, PhD, FRCP, FRCPath, Mark Caswell, FRCPath, Helen Jane Campbell, FRCP, MD, FRCPath, Barry Pizer, MBChB, PhD

Blood (2013) 122 (21): 1402.

https://doi.org/10.1182/blood.V122.21.1402.1402

Published: 2013

Journal Articles

Ezh2 Loss Accelerates JAK2V617F-Driven Primary Myelofibrosis

Takahisa Tomioka, BS, Goro Sashida, MD, PhD, Kotaro Shide, MD, PhD, Kazuya Shimoda, MD, PhD, Naoto Yamaguchi, PhD, Atsushi Iwama, MD, PhD

Blood (2013) 122 (21): 110.

https://doi.org/10.1182/blood.V122.21.110.110

Published: 2013

NARROW

Mir-29 Maintains the Acute Myeloid Leukemia Epigenome By Regulating CBX2

Mutant TET2 Allele Dosage Affects Response to 5-Azacitidine in Acute Myeloid Leukemia

Downregulation of MDM2 Leads to Anti-Proliferative Effects through Activation of p53-Associated Pathway Mediated By Both Dual Inhibitor MX69 and Mir-548c-3p in Multiple Myeloma

Both Arid1b and Arid2 Are Tumor Suppressors in MLL-AF9 Leukemogenesis

An Alternative Pathway Specific Flow Cytometric Assay to Detect Complement Activation in Atypical Hemolytic Uremic Syndrome (aHUS)

Integrin Activity Reduces Immunogenic Cell Death By Inhibiting Cell Surface Presentation of ERp57 and Calreticulin

The Histone Methyltransferase Setd8 Alters the Chromatin Landscape and Regulates the Expression of Key Transcription Factors during Erythroid Differentiation

Epigenetic Regulation and Therapeutic Targeting in Myeloma

Temporal and Spatially Regulated Oncogenic KIT Expression and Loss of Dnmt3a Cooperate to Drive MPN Development: Role of PI3Kinase in Dnmt3a Loss Induced Hyperproliferation in Myeloid Cells

FANCN Hypomorphic Mutation Retains BRCA1 Binding Domain

The Novel Thiosemicarbazone Derivative Coti-2 Induces Mitochondrial Apoptosis in Acute Myeloid Leukemia Cells Via a p53-Independent Mechanism

Integrative Analysis of the Mutational Landscape of Mouse and Human AML Identifies Functionally Relevant Leukemia Disease Alleles

GABP Transcription Factor Is Required for B Lymphocyte Maturation and Plasma Cell Development

Desuppressed Expressionsof MiR-29 targetsdisturb the Leukemeugenesis of MLL-AF9

Megatal, Crispr/Cas9, and Talen T-Cell Receptor Gene Editing

MiR-29a is Essential in Leukemic Transformation and Maintaining Hematopoietic Stem Cell Self-Renewal

PRL2 Phosphatase Regulate Early Stage T-Cell Development through Fine-Tuning SCF/Kit Signaling

Heightened DNA Damage Response and p53 Activation In MiR-155 Null Cells Are Context Specific and Aid Dependent

No Evidence For Routine CSF Cytology In Detecting Asymptomatic CNS Relapse In Children With Acute Lymphoblastic Leukaemia: 20 Years Experience Of a UK Primary Treatment Centre

Ezh2 Loss Accelerates JAK2V617F-Driven Primary Myelofibrosis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only